These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 44538)

  • 1. [Neurotransmitters, drugs and neuropsychiatric diseases (author's transl)].
    Relja M; Lackvoić Z
    Lijec Vjesn; 1979 Oct; 101(10):609-16. PubMed ID: 44538
    [No Abstract]   [Full Text] [Related]  

  • 2. Basal ganglia disease.
    Marsden CD
    Lancet; 1982 Nov; 2(8308):1141-7. PubMed ID: 6128460
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
    Davis KL; Hollister LE; Berger PA; Barchas JD
    Psychopharmacol Commun; 1975; 1(5):533-43. PubMed ID: 132684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathology of endogenous psychoses].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):253-63. PubMed ID: 45342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of basal ganglia in rhythmic movement.
    Freund HJ; Hefter H
    Adv Neurol; 1993; 60():88-92. PubMed ID: 8420222
    [No Abstract]   [Full Text] [Related]  

  • 6. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

  • 7. Error processing in normal aging and in basal ganglia disorders.
    Beste C; Willemssen R; Saft C; Falkenstein M
    Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central organization of transmitter systems].
    Cuénod M; Reubi JC
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):205-15. PubMed ID: 45340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basal ganglia lesions and neurotransmitters].
    Yoshida M
    Nihon Rinsho; 1978; 36(1):58-64. PubMed ID: 24766
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuropharmacological data on the striatum].
    Allain H; Reymann JM; Bentue Ferrer B; Menault F; Van Den Driessche J
    Encephale; 1979; 5(3):219-37. PubMed ID: 39737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basal ganglia disease. Functional neuroanatomy and therapeutic perspectives].
    Ostergaard K; Sunde NA; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5480-3. PubMed ID: 11068522
    [No Abstract]   [Full Text] [Related]  

  • 12. Reflex recovery curves in extrapyramidal disorders.
    Sax DS; Johnson TL; Cooper IS
    Adv Neurol; 1976; 14():285-96. PubMed ID: 133596
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotransmitters and neurodegenerative disorders.
    Kanazawa I
    Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The basal ganglia. A clinical and physiopathological approach (author's transl)].
    Rondot P
    J Physiol (Paris); 1981 Apr; 77(1):119-30. PubMed ID: 6453222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peptide neurotransmitters and extrapyramidal disorders].
    Tan MX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):246-7. PubMed ID: 2416519
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of dexbenzetimide (Tremblex - Gedeon Richter) on postneuroleptic extrapyramidal syndromes (author's transl)].
    Firko M; Morasiewicz J; Puchała G
    Psychiatr Pol; 1981; 15(2):139-44. PubMed ID: 6118905
    [No Abstract]   [Full Text] [Related]  

  • 18. [A review on neurotransmitter in clinical neurology (author's transl)].
    Kanazawa I
    No To Shinkei; 1977 Dec; 29(12):1245-60. PubMed ID: 74257
    [No Abstract]   [Full Text] [Related]  

  • 19. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
    Wray SR; Melville GN; Grell GA; Edge PC
    West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitric oxide as a physiopathological factor in neuropsychiatric disorders.
    Akyol O; Zoroglu SS; Armutcu F; Sahin S; Gurel A
    In Vivo; 2004; 18(3):377-90. PubMed ID: 15341194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.